Nifty Pharma Index - Bulls are Losing the Ground

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  
Top Ad

Find Out

How to Find One Stock with Crorepati Potential? >> READ MORE

Nifty Pharma Index - Bulls are Losing the Ground

Mar 16, 2022

Indian share markets surged today, tracking an overnight rise in US stocks, even as strong gains seen in most Asian markets earlier in the day, fizzled out.

As Indian equity market recover from the lows, the Nifty pharma index too witnessed a sharp recovery from ~12,300 to ~13,500 levels.


The index is resisting at 200DEMA (13,480) and slips lower to form the bearish candlestick pattern.

On 2hrs chart, the bearish harmonic pattern is visible right at the 200DEMA.

The bulls are losing the ground as they witness multiple bearish candlestick pattern which indicates the bears are gruffing.

Additionally, the bearish crossover on MACD signals an end to bullish momentum.

If bulls fail to close cross 13,689, it's everything for bears on the plate.

Currently, the Nifty pharma index is trading at 13,331 levels.

From the index, Piramal Enterprises and Zydus Lifesciences are the top gainers. While Cipla and Sun Pharma are among the top losers.

Note that pharma stocks have been in focus of late as companies which are exporting drugs seem to be benefitting amid the ongoing geopolitical tensions.

Last week, we saw big uptrend in select pharma companies. Cipla had rallied around 6% on Friday while Take Solutions and IOL Chemicals & Pharma also surged.

For more detailed updates, check the latest NIFTY Pharma stock results and see the latest NIFTY Pharma long term chart.

If you're interested in being part of my charting journey as I share how to create wealth from the profitable trade setup, join my telegram channel - Fast Profits Daily.

You'll get access to the best trading ideas in the stock market.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...

Brijesh Bhatia

Brijesh Bhatia Research Analyst and expert chartist, is the editor of Alpha Wave Profits. Fully committed to his craft, Brijesh has mastered the art of making money by trading using technical analysis. Brijesh has an MBA from ICFAI and 16 years of experience in India's financial markets. He began his career on Dalal Street as commodities dealer and it wasn't long before he developed his own unique trading system. Brijesh worked on his trading system until it could be expected to deliver 5 units of return for every unit of risk.

Equitymaster requests your view! Post a comment on "Nifty Pharma Index - Bulls are Losing the Ground". Click here!


More Views on News

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling (Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover? (Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Jun 24, 2022 (Close)